Posvax
The startup develops prophylactic vaccines and anticancer drugs using Virus-like Particle (VLP) technology, which is based on protein structure analysis and immunological research. This approach aims to enhance public health by providing effective preventive measures against infectious diseases and cancer.
Traction –/10
Seoul, South Korea · HQ
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops prophylactic vaccines and anticancer drugs using Virus-like Particle (VLP) technology, which is based on protein structure analysis and immunological research. This approach aims to enhance public health by providing effective preventive measures against infectious diseases and cancer.